Integrative Analysis of Lung Cancer Etiology and Risk Consortium (Amos Lab)

GWAS Intake Form


To be eligible to participate in the Integral Project, studies must have:


Genome-wide genotyping data or germline DNA for genotyping, i.e.: existing genome-wide genotyping data, or germline DNA available for new genotyping, or blood/buccal samples for germline DNA isolation and genotyping. Basic phenotype data (e.g. age at diagnosis, gender, family history of breast cancer) Appropriate ethics approval for genetic studies and data sharing See the Integral Project Summary for more information, including principles and governance, and approximate timeline.

Please complete the study inventory if you are interested in participating in the Integral Project. We are performing an initial evaluation of interested studies that responded by the deadline. We will consider additional expressions of interest until reaching the desired target. This inventory is for planning purposes only and implies no commitment to participate.

PLEASE NOTE: If you have any questions, please contact the Project Manager, Kathryn Edwards, at